1. Home
  2. BOC vs LRMR Comparison

BOC vs LRMR Comparison

Compare BOC & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boston Omaha Corporation

BOC

Boston Omaha Corporation

HOLD

Current Price

$12.23

Market Cap

388.4M

Sector

N/A

ML Signal

HOLD

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

HOLD

Current Price

$4.77

Market Cap

455.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOC
LRMR
Founded
2009
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
388.4M
455.8M
IPO Year
2010
2014

Fundamental Metrics

Financial Performance
Metric
BOC
LRMR
Price
$12.23
$4.77
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$16.50
AVG Volume (30 Days)
139.4K
1.7M
Earning Date
05-13-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$114,376,348.00
N/A
Revenue This Year
$4.46
N/A
Revenue Next Year
N/A
$1,816.14
P/E Ratio
N/A
N/A
Revenue Growth
5.64
N/A
52 Week Low
$11.03
$1.73
52 Week High
$15.72
$6.42

Technical Indicators

Market Signals
Indicator
BOC
LRMR
Relative Strength Index (RSI) 47.96 50.82
Support Level $12.01 $3.14
Resistance Level $12.87 $5.36
Average True Range (ATR) 0.38 0.29
MACD 0.01 -0.02
Stochastic Oscillator 66.29 49.12

Price Performance

Historical Comparison
BOC
LRMR

About BOC Boston Omaha Corporation

Boston Omaha Corp is a United States based company which invests in real estate. Its operations include its ownership of multiple billboards in Florida, Georgia, Wisconsin, and Alabama and equity method investments in several real estate companies. The company operates four separate lines of business, outdoor billboard advertising, the broadband services industry, the insurance industry, and the asset management industry. Company generate revenue from outdoor advertising through the leasing of advertising space on billboards. It also generate revenue from commissions on surety bond sales and account for commissions and principally from internet services and is recognized on a straight-line basis over the term of the contract in the period the services are rendered.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: